Skip to main navigation
Skip to search
Skip to main content
Glasgow Caledonian University Home
Help & FAQ
Link opens in a new tab
Search content at Glasgow Caledonian University
Home
Profiles
Organisational Units
Research Outputs
Projects
Student theses
Activities
Prizes
Equipment
EPMA position paper in cancer: current overview and future perspectives
Godfrey Grech
, Xianquan Zhan
, Byong Chul Yoo
, Rostylav Bubnov
,
Suzanne Hagan
, Romano Danesi
, Giorgio Vittadini
, Dominic M. Desiderio
Vision Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
91
Citations (Scopus)
279
Downloads (Pure)
Overview
Fingerprint
Research Outputs
(3)
Fingerprint
Dive into the research topics of 'EPMA position paper in cancer: current overview and future perspectives'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Biology
33%
Cancer Initiation
33%
Cancer Predisposition
33%
Cancer Progression
33%
Cancer Risk
33%
Cancer Treatment
33%
Care Provision
33%
Cellular Biology
33%
Competencies
33%
Cost-benefit Analysis
33%
Data Protection
33%
Data Sharing
33%
Drug Development
33%
Early Cancer Detection
33%
Early Screening
33%
Educational Program
33%
Harmonised Guidelines
33%
Health Care Costs
33%
Healthcare
33%
Healthcare Professionals
33%
Improper Use
33%
In Cancer
100%
Individuals at Risk
33%
Major Risk Factors
33%
Management Efficiency
33%
Monogenic
33%
Patient's Will
33%
Personalized Medicine
100%
Population Screening
33%
Position Paper
100%
Predictive Marker
33%
Predictive Medicine
66%
Predisposition Factor
33%
Preventive Measures
33%
Preventive Medicine
66%
Preventive Strategies
33%
Primary Care
33%
Quality of Life Improvement
33%
Risk Factors
33%
Screening Diagnosis
33%
Secondary Care
33%
Tertiary Care
33%
Training Program
33%
Treatment Outcome
33%
Well-defined
66%
Medicine and Dentistry
Cancer Growth
33%
Cancer Predisposing Syndrome
33%
Cancer Susceptibility
33%
Cancer Therapy
33%
Cost Benefit Analysis
33%
Early Cancer Diagnosis
33%
Health Care Cost
33%
Malignant Neoplasm
100%
Mass Screening
33%
Personalized Medicine
100%
Predictive Marker
33%
Primary Health Care
33%
Quality of Life
33%
Secondary Care
33%
Tertiary Care
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Growth
16%
Cancer Susceptibility
16%
Drug Development
16%
Malignant Neoplasm
100%
Syndrome
16%
Biochemistry, Genetics and Molecular Biology
Mass Screening
50%
Solution and Solubility
100%